Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Elevidys’ Age-Restricted Indication Not Negotiable, CBER’s Peter Marks Told Sarepta
Aug 08 2023
•
By
Sue Sutter
CBER Director Peter Marks told Sarepta his decision on an age-limited indication was not up for negotiation. • Source: Shutterstock
More from Drug Review Profiles
More from Product Reviews